Following Up On Follow-On Biologics
Five years ago, the Federal Trade Commission waded into the debate regarding the benefits and potential competition issues posed by the introduction of "follow-on biologics." Now, some three years after Congress...To view the full article, register now.
Already a subscriber? Click here to view full article